Abstract:
945,055. Locks. G. M. PHILLIPS. July 10, 1961 [April 11, 1960], No. 12900/60. Heading B7S. [Also in Division F3] In a lock for raising and lowering waterborne vessels between two different water levels comprising a lock basin 1 in communication with the lower water level, a floating lock structure 5 mounted on trunnions movable in arcuate rails on the walls of the basin, the lock structure having a channel 11 capable of communicating at one end with the upper water level when the structure is in a horizontal position, and a guillotine gate 18 for sealing the upper from the lower water level, the structure is tiltable so that the other end thereof communicates with the lower level, the arrangement being such that when the lock structure is horizontal a vessel can proceed from the upper water level into the structure and when the structure has been tilted the vessel can then proceed to the lower water level. The basin contains safety booms 3 and 4, each comprising two arcuate members upstanding from the water level, spaced apart a width equal to the width of the lock, and mounted on a turntable.
Abstract:
A method of inhibiting bleeding from an open surgical site includes mixing (i) a flowable gel solution comprising a biopolymer dissolved in a first solvent and (ii) a flowable hardener solution comprising a cross-linking agent dissolved in a second solvent to form a flowable hemostatic gel composition. The method also includes applying the flowable hemostatic gel composition to the open surgical site. The cross-linking agent links chains of the biopolymer together to form a solid hydrogel that inhibits bleeding from the surgical site.
Abstract:
A flowable hemostatic gel composition is provided for use at a site of a defect within a biological tissue. The flowable hemostatic gel composition includes a flowable gel solution that includes a biopolymer dissolved in a first solvent. The biopolymer is configured to cross-link with red blood cells at the site to facilitate clot formation at the site. The flowable hemostatic gel composition also includes at least one additional active agent.
Abstract:
Devices, systems, and methods useful to engage tissue using suction and to perform medical procedures during sectional engagement. The present disclosure includes disclosure of a tension apparatus, comprising an elongated portion; and a head portion at a distal end of the elongated portion, the head portion comprising one or more arms, whereby a suction lumen extending along the elongated portion and the one or more arms terminates at one or more suction openings at each of the one or more arms.
Abstract:
A method of inhibiting bleeding from an open surgical site includes mixing (i) a flowable gel solution comprising a biopolymer dissolved in a first solvent and (ii) a flowable hardener solution comprising a cross-linking agent dissolved in a second solvent to form a flowable hemostatic gel composition. The method also includes applying the flowable hemostatic gel composition to the open surgical site. The cross-linking agent links chains of the biopolymer together to form a solid hydrogel that inhibits bleeding from the surgical site.
Abstract:
The present invention provides a minimally invasive surgical applicator device. The device is useful in the application of bone wax during surgical procedures to halt or reduce bone bleeding. The device may be sterilized for re-use or may be made disposable.
Abstract:
One aspect of the present invention discloses a circumferential sleeve made from a single pre-cut blank with no additional material (other than adhesive) added to the blank. The circumferential sleeve has a strip that protrudes from the sleeve and one end of the strip is contiguous to a first portion sleeve such as the bottom edge and the other end of the strip is attached to a portion of the sleeve, such as the rear panel. The strip can be arcuate or L-shaped and permits a food container to stand upright.
Abstract:
A hemostatic system includes an inner tube and an injection sheath coupled to the inner tube. The injection sheath houses at least a section of the inner tube. The inner tube defines a first lumen configured to channel a fluid therethrough, and the injection sheath defines a second lumen configured to channel a hemocoagulant agent therethrough. An injection device is positionable within the injection sheath to facilitate channeling the hemocoagulant agent through the second lumen. The injection device defines a third lumen in fluid communication with the first lumen when the injection device is positioned within the injection sheath. The injection device includes a valve that is moveable to selectively restrict access to a portion of the injection device.